You can view the research column published every month by SMC Laboratories.
2025.03.21
Today, we would like to introduce our experience of the bleomycin-induced IPF study. One of our most re…
2025.03.14
In this article, we introduce our COPD model. Why Choose Our COPD Model? ✅Clinically Relevant Evaluatio…
2025.03.07
We are pleased to share with you the latest material introducing our CCl4 model, which should provide valuable…
2025.02.27
We are pleased to introduce the latest materials showcasing our lung disease models, designed to provide valua…
2025.02.21
We are pleased to share with you the latest material introducing our BDL model, which should provide valuable …
2025.02.14
We are pleased to share the latest material introducing our UUO model, which should provide valuable insights …
2025.02.07
Pulse oximetry analysis begins in IPF preclinical pharmacology study. We offer the Idiopathic Pulmonary…
2025.02.06
In recent years, we have received many requests about our services, starting from the establishment of patholo…
2025.02.05
If you are considering using a lung fibrosis model in a drug efficacy study, you can maximize the efficacy of …
2025.02.04
We introduce some of the data, the results for Infliximab (TNF-a antibody), from the full version of the IBD m…
We can help you advance your research.